Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis
Journal of the American College of Cardiology,
Journal Year:
2025,
Volume and Issue:
85(9), P. 944 - 964
Published: March 1, 2025
Language: Английский
Preventing cerebrovascular events in patients undergoing TAVR: the current and future landscape
Future Cardiology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 3
Published: March 31, 2025
Language: Английский
Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?
Clement Tan,
No information about this author
Mark Higgins,
No information about this author
Vaikunthan Thanabalasingam
No information about this author
et al.
Medicina,
Journal Year:
2025,
Volume and Issue:
61(2), P. 305 - 305
Published: Feb. 10, 2025
Stroke
is
a
devastating
complication
of
cardiovascular
interventions.
Intraprocedural
stroke
well-documented
and
feared
risk
cardiac
percutaneous
transcatheter
procedures.
If
clinically
significant
strokes
are
absent,
silent
remain
the
next
in
line
to
pose
large
concerns
related
future
cognitive
decline,
risk,
overall
increased
morbidity
mortality.
Cerebral
protection
devices
(CPD)
developed
overtime
aim
neutralize
this
through
either
capture-based
filter
or
deflector
mechanism.
Many
CPDs
exist
currently,
each
one
unique,
with
varying
degrees
evidence.
The
adoption
has
allowed
procedures
be
carried
out
patients
high
thromboembolic
risks
who
may
have
historically
been
discommended.
Though
skewed
towards
certain
procedures,
body
evidence
still
present
across
other
This
review
will
discuss
clinical
importance
respective
rates,
updated
surrounding
CPDs,
differing
opinions
types
cost
benefits,
what
lies
ahead
for
within
realm
undertaken
catheterization
laboratories.
Language: Английский
Transcatheter Aortic Valve Implantation and Replacement: The Latest Advances and Prospects
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(6), P. 1844 - 1844
Published: March 9, 2025
Transcatheter
aortic
valve
replacement
(TAVR)
has
revolutionized
the
treatment
of
stenosis,
particularly
in
patients
at
high
risk
adverse
events
for
traditional
open-heart
surgery.
Since
early
2000s,
TAVR
evolved
rapidly
with
advancements
device
technology,
procedural
techniques,
and
patient
selection
criteria.
Over
past
20
years,
this
catheter-based
procedure
significantly
improved
survival
quality
life,
demonstrating
both
safety
efficacy
TAVR,
even
low
surgical
risk.
This
paper
reviews
latest
advances
design
strategies
treating
stenosis.
It
explores
challenges
long-term
outcomes
given
younger
age
undergoing
prospects
emerging
technologies
to
improve
outcomes.
Language: Английский